Janus Henderson Group PLC Ptc Therapeutics, Inc. Transaction History
Janus Henderson Group PLC
- $174 Billion
- Q1 2025
A detailed history of Janus Henderson Group PLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 2,916,729 shares of PTCT stock, worth $135 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
2,916,729
Previous 2,325,915
25.4%
Holding current value
$135 Million
Previous $105 Million
41.57%
% of portfolio
0.09%
Previous 0.06%
Shares
25 transactions
Others Institutions Holding PTCT
# of Institutions
285Shares Held
78.8MCall Options Held
223KPut Options Held
156K-
Vanguard Group Inc Valley Forge, PA8.61MShares$399 Million0.01% of portfolio
-
Black Rock Inc. New York, NY7.77MShares$361 Million0.01% of portfolio
-
Rtw Investments, LP New York, NY7.48MShares$347 Million6.25% of portfolio
-
Armistice Capital, LLC New York, NY5.43MShares$252 Million4.22% of portfolio
-
Wellington Management Group LLP Boston, MA5.42MShares$251 Million0.05% of portfolio
About PTC THERAPEUTICS, INC.
- Ticker PTCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,541,000
- Market Cap $3.32B
- Description
- PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...